Kinetic Capital Partners

CXIP Labs is a developer of NFT infrastructure solutions for the web3 ecosystem.

BlockApps, Inc. is a blockchain technology company that specializes in providing a platform for developing and deploying Ethereum-based applications. Its primary offering, BlockApps STRATO, is an Ethereum-compliant platform designed for the development, deployment, and management of enterprise blockchain applications. Additionally, BlockApps offers a consortium blockchain network that facilitates the creation of hybrid private, consortium, and public blockchains. The company's services cater to a diverse clientele, including software startups, IT firms, industry-owned businesses, and Fortune 500 corporations. Founded in 2015 and headquartered in Brooklyn, New York, BlockApps aims to drive the adoption of blockchain technology by enabling clients to build and manage decentralized applications securely and effectively, while also streamlining processes and enhancing data visibility.

Worldcoin is a global digital currency initiative aimed at distributing a free share of its currency to every individual on Earth. The platform focuses on enhancing privacy and transparency through a permissionless blockchain. Worldcoin employs an iris-scanning device that creates a unique digital identity known as World ID. This system not only facilitates the issuance of its digital currency but also securely stores biometric information, which helps prevent fraudulent account creation by discouraging spammers from registering multiple times. Through these innovations, Worldcoin seeks to promote equitable access to digital currency while maintaining user privacy.

Dtravel is a decentralized platform for the home-sharing economy facilitating short and long-term stays payable with cryptocurrency and traditional payment methods.

Flare Networks is a new blockchain network based on the Flare Consensus Protocol – the first Turing Complete Federated Byzantine Agreement protocol.

SubDAO Network is a DAO management platform that aims to provide a chain of tools to facilitate DAO’s creation. SubDAO is a DAO infrastructure based on Polkadot, where any decentralized organization is allowed to conveniently create and manage a DAO. SubDAO does not only connect DAO with DApps to realize DAO’s cross-chain management, but also bridges Web 2.0 and Web 3.0.

Convergence Finance is a decentralized exchange platform focused on tokenized real-world assets. By utilizing smart contracts, the platform aims to enhance liquidity and facilitate the trading of both real-world and crypto-native assets. Its innovative automated market maker model is designed to provide greater transparency and inclusivity for investors, transforming the way assets are traded in the digital landscape. Through this approach, Convergence Finance seeks to bridge traditional finance with blockchain technology, making asset trading more accessible and efficient for a broader audience.

Cere Network is a company that specializes in developing a blockchain-based customer relationship management (CRM) ecosystem aimed at enhancing data integration and collaboration. Founded in 2019 and headquartered in San Francisco, California, the company offers a platform that extracts customer data from various traditional CRM and customer data systems. By leveraging blockchain technology, Cere captures the entire customer journey and securely stores key user data, including purchases and achievements, in user wallets. This approach enables businesses to gain valuable customer insights while allowing clients to maintain control over their data. The platform also incorporates a token system, which facilitates payment for services within the ecosystem.

Opium Team operates a blockchain-based financial platform that focuses on the creation, settlement, and trading of derivatives. Founded in 2018 and based in Rotterdam, the Netherlands, the company provides a decentralized protocol for various financial applications, including trade settlement and risk management. Users can create derivatives, utilize oracles for asset pricing, and manage portfolios within this ecosystem. The platform also features smart contracts, a crypto wallet, and an API, facilitating a transparent and audited framework for trading products like ETH futures, gas options, and synthetic pre-markets for decentralized finance (DeFi) tokens. By leveraging innovative technology, Opium Team aims to disrupt traditional financial services with its comprehensive range of offerings.

Reef Finance LLC is a cross-chain decentralized finance (DeFi) platform developed on the Polkadot network. The company offers a liquidity aggregator and a yield engine that facilitates trading by connecting users to liquidity from both centralized and decentralized exchanges. Additionally, it provides a range of financial services, including smart lending, borrowing, staking, and mining, all enhanced by an artificial intelligence-based personalized yield engine. Founded in 2011, Reef Finance is headquartered in Wilmington, Delaware.

Linear Finance owns and operates an application for cross-chain compatible, decentralized delta-one asset protocol to create, manage, and trade synthetic assets with unlimited liquidity. The company caters to bitcoin, crude oil, coffee, market indices, e-sports, and sustainability industries. Linear Finance is headquartered in New Territories, Hong Kong.

Reef Finance LLC is a cross-chain decentralized finance (DeFi) platform developed on the Polkadot network. The company offers a liquidity aggregator and a yield engine that facilitates trading by connecting users to liquidity from both centralized and decentralized exchanges. Additionally, it provides a range of financial services, including smart lending, borrowing, staking, and mining, all enhanced by an artificial intelligence-based personalized yield engine. Founded in 2011, Reef Finance is headquartered in Wilmington, Delaware.

ThunderCore operates as a high-performance public blockchain that is compatible with the Ethereum Virtual Machine (EVM). It aims to enhance the scalability of decentralized applications by offering higher throughput, faster confirmation times, and lower transaction costs. The blockchain is built on innovative research conducted by Professors Shi and Pass from Cornell University, utilizing a unique consensus protocol that addresses the limitations of traditional Nakamoto consensus. This ensures fully decentralized trust while significantly boosting performance. Additionally, ThunderCore provides a crypto token designed to facilitate rapid and secure transactions, supported by a robust blockchain protocol that employs rigorous mathematical security analysis.

Eximchain operates a digital platform designed to streamline the global sourcing process for small and medium-sized businesses. By offering a comprehensive service that includes data-driven analysis and customized supplier recommendations, Eximchain facilitates direct connections between enterprises and suppliers. The company has developed a reputation platform that assesses supplier reliability based on transaction history. Additionally, it digitizes traditional contracts and management processes, securely storing these documents and performance proofs on the blockchain. By leveraging blockchain technology, Eximchain aims to eliminate barriers in the supply chain, fostering an efficient, transparent, and secure network for businesses of all sizes. Headquartered in the United States, Eximchain is focused on improving the efficiency of business transactions and information sharing.

Bluzelle Networks Inc. specializes in developing a decentralized, blockchain-based database platform that addresses data storage and management challenges for decentralized applications. By distributing data across multiple nodes rather than relying on a centralized cloud system, the platform enhances security, scalability, and availability. It allows individuals to rent out their computer storage, earning tokens, while decentralized application developers use these tokens for data management. Founded in 2014 and headquartered in Singapore, with an additional office in Vancouver, Canada, Bluzelle serves a diverse clientele ranging from small and medium enterprises to global corporations, providing a fully integrated stack of blockchain applications, middleware, and data services tailored to meet various business needs.

Viscardia, Inc., a medical device company, develops and commercializes a medical device therapy for patients with medical refractory heart failure. The company develops a fully implantable electronic, sensor, and electrode system for delivering chronic electrical stimulation for mediating thoracic pressure augmentation. Its therapy uses the patient’s own thoracic musculature to improve cardiac filling and output, and relieve symptoms resulting from hemodynamic insufficiency. The company was incorporated in 2015 and is based in Beaverton, Oregon.

Protiva Biotherapeutics, Inc., a development stage biotechnology company, develops nucleic acid based pharmaceutical products. The company focuses on developing products to fight various human diseases, such as cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. Its products include Pro 1, a tumor cell growth inhibitor, which kills tumor cells and inhibits tumor growth; Pro-101, an siRNA product that acts to inhibit the production of a protein involved in tumor growth; Pro-B, which acts to inhibit the expression of a protein, apolipoprotein B; Pro-EBOV and Pro-MARV that act to inhibit the replication of the Ebola and Marburg viruses; and Stable Nucleic-Acid Lipid Particle technology, an encapsulation and delivery system for nucleic acid payloads, such as short interfering RNA (siRNA), to target cells. The company also develops Hepatitis siRNA products for the treatment of hepatitis B and C. Protiva Biotherapeutics, Inc. has a research and development facility in Vancouver, Canada. The company was founded in 2000 and is based in Seattle, Washington. As of May 30, 2008, Protiva Biotherapeutics, Inc. operates as a subsidiary of Tekmira Pharmaceuticals Corp.

USystems specializes in the design, development, and manufacturing of advanced technology solutions in two primary sectors: medical imaging and data center infrastructure. In the medical field, the company creates innovative breast ultrasound systems that aid radiologists in detecting breast cancer, particularly in women with dense breast tissue, by providing detailed 3D ultrasound images for improved visualization. In the realm of data centers, USystems manufactures cooling systems that enhance sustainability while reducing noise and heat. Their offerings include air-cooled and soundproof rapid deployment micro data centers equipped with intelligent features, such as real-time alarms and optional security monitoring, to safeguard IT equipment and optimize operational efficiency. Through its cutting-edge designs and state-of-the-art manufacturing processes, USystems is committed to delivering high-quality solutions that address critical challenges in both healthcare and information technology.

USystems specializes in the design, development, and manufacturing of advanced technology solutions in two primary sectors: medical imaging and data center infrastructure. In the medical field, the company creates innovative breast ultrasound systems that aid radiologists in detecting breast cancer, particularly in women with dense breast tissue, by providing detailed 3D ultrasound images for improved visualization. In the realm of data centers, USystems manufactures cooling systems that enhance sustainability while reducing noise and heat. Their offerings include air-cooled and soundproof rapid deployment micro data centers equipped with intelligent features, such as real-time alarms and optional security monitoring, to safeguard IT equipment and optimize operational efficiency. Through its cutting-edge designs and state-of-the-art manufacturing processes, USystems is committed to delivering high-quality solutions that address critical challenges in both healthcare and information technology.

AgInfoLink Inc. designs and develops traceability solutions for the food industry. It offers data collection, secure data transmission, data warehousing, reporting, and analysis tools for linking information for individual animal management, regulatory compliance, and business performance. The company provides Pony Express, a data sharing solution to create and customize a data sharing network for supply chain; BeefLink, a personal computer-based data collection and management system to capture and store data automatically from RFID and barcode tags, scales, and other devices; AgInfoReports and AgInfoSheets reporting systems; and AgMobile, a handheld unit and wireless RFID reader that allows livestock producers to identify animals, record data, and reference historical data. AgInfoLink, Inc. also offers CattleCard, a data collection solution, for customers without computers, to collect group data and individual data using a barcode label sticker and RFID identifier; Tag Tracker, a rugged hand-held wireless RFID reader reads an RFID tag and communicates with a base station; and Animal Logger, a solution for collecting NAIS required and basic animal movement information, as well as WebReporting and Decision Pro tools, and processed verification programs. It serves state regulators, meat processors, retail/foodservice, and livestock producers. The company was founded in 1997 and is based in Longmont, Colorado.

Protiva Biotherapeutics, Inc., a development stage biotechnology company, develops nucleic acid based pharmaceutical products. The company focuses on developing products to fight various human diseases, such as cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. Its products include Pro 1, a tumor cell growth inhibitor, which kills tumor cells and inhibits tumor growth; Pro-101, an siRNA product that acts to inhibit the production of a protein involved in tumor growth; Pro-B, which acts to inhibit the expression of a protein, apolipoprotein B; Pro-EBOV and Pro-MARV that act to inhibit the replication of the Ebola and Marburg viruses; and Stable Nucleic-Acid Lipid Particle technology, an encapsulation and delivery system for nucleic acid payloads, such as short interfering RNA (siRNA), to target cells. The company also develops Hepatitis siRNA products for the treatment of hepatitis B and C. Protiva Biotherapeutics, Inc. has a research and development facility in Vancouver, Canada. The company was founded in 2000 and is based in Seattle, Washington. As of May 30, 2008, Protiva Biotherapeutics, Inc. operates as a subsidiary of Tekmira Pharmaceuticals Corp.